Latest News
Electronic Health Record Data May Predict Early Autism
COVID-19 Vaccine Primary Series Coverage 76% in Adults 60 Years and Older
5 Birth Defect Risk Factors Patients Should Know
Jesduvroq Approved for Anemia of CKD in Patients on Dialysis
Maker of Weight-Loss Drug Wegovy Ramps Up Production to Meet Demand
Trends in Chronic Pain and Its Management Among Nursing Home Residents With Dementia
FDA Revises Paxlovid, Lagevrio EUAs Removing Positive COVID-19 Test Requirement
FDA Issues Warning to Companies Selling Products Claiming to Treat Mpox
More Support and Critique of AAP Guideline for Childhood Obesity
Latest Features
A Technicality Could Keep RSV Shots From Kids in Need
The Vaccines for Children program may not cover the RSV shot for babies because it’s not technically a vaccine.
We Have Better Obesity Medications, but Access Is Lagging
Obesity experts discuss the cost of newer obesity medications (eg, GLP-1 agonists) and access issues, including Ozempic shortages.
AANP Health Policy Conference Debrief
AANP President Dr April Kapu provides a debrief on health policy issues facing NPs including the ICAN Act and APRN Compact.
Helping Clinicians Cope With Moral Distress Can Improve Patient Care
A central objective of addressing moral distress is to permit clinicians to effectively perform their professional functions and thus better help patients.
How COVID-19 Pandemic Affected ADHD Treatment
The COVID-19 pandemic has had a significant impact on children and adults with ADHD. This case explores the effects long COVID has had on an adult patient with ADHD.
NP/PA Practice Corner
What the Buprenorphine X-Waiver Removal Means for Clinicians
AANP and AAPA Presidents discuss how elimination of the X-Waiver and patient caps for buprenorphine prescription for opioid use disorder will affect clinical practice.
NP and PA Presidents Discuss Workforce Shortage and the Future
NPs and PAs continue to rank high on the latest U.S. News & World Report Best Jobs list.
CME/CE
Activity Type: Hosted
Potential of Next Generation BTK Inhibitors in CLL/SLL | myCME
1.00 CME: MD Anderson Cancer Center provides expert insights on recent trial data for emerging BTK inhibitors that impact CLL/SLL treatments. Exp 1/31/24
Activity Type: Linkout
Improving Outcomes in CAR T-cell Therapy for DLBCL | myCME
1.00 CME CE: Patients with DLBCL face poor outcomes with salvage treatments. CAR T-cell therapy shows promise for patients with relapse after chemoimmunotherapy and ASCT. Exp 10/27/23
More
- Loading...
Loading...
Loading... 
Loading...